WSTAM
ABMD

Wilbanks Smith & Thomas Asset Management’s Abiomed Inc ABMD Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,036
Closed -$500K – 523
2022
Q3 		$500K Hold
2,036
– – 0.02% 287
2022
Q2 		$504K Sell
2,036
-3
-0.1% -$810 0.02% 296
2022
Q1 		$583K Buy
2,039
+3
+0.1% +$923 0.02% 284
2021
Q4 		$731K Hold
2,036
– – 0.03% 276
2021
Q3 		$663K Hold
2,036
– – 0.03% 268
2021
Q2 		$635K Hold
2,036
– – 0.02% 276
2021
Q1 		$649K Hold
2,036
– – 0.03% 257
2020
Q4 		$660K Hold
2,036
– – 0.03% 231
2020
Q3 		$564K Hold
2,036
– – 0.03% 228
2020
Q2 		$492K Hold
2,036
– – 0.03% 238
2020
Q1 		$296K Hold
2,036
– – 0.02% 285
2019
Q4 		$347K Hold
2,036
– – 0.02% 308
2019
Q3 		$362K Sell
2,036
-25
-1% -$5.4K 0.02% 277
2019
Q2 		$537K Sell
2,061
-5
-0.2% -$1.33K 0.03% 223
2019
Q1 		$590K Sell
2,066
-10
-0.5% -$3.32K 0.04% 218
2018
Q4 		$675K Hold
2,076
– – 0.05% 177
2018
Q3 		$934K Sell
2,076
-2
-0.1% -$788 0.06% 175
2018
Q2 		$850K Sell
2,078
-294
-12% -$107K 0.07% 146
2018
Q1 		$690K Sell
2,372
-85
-3% -$21.5K 0.06% 163
2017
Q4 		$460K Buy
2,457
+161
+7% +$30.1K 0.04% 206
2017
Q3 		$387K Hold
2,296
– – 0.03% 219
2017
Q2 		$329K Hold
2,296
– – 0.03% 224
2017
Q1 		$287K Hold
2,296
– – 0.02% 243
2016
Q4 		$259K Sell
2,296
-5
-0.2% -$579 0.02% 250
2016
Q3 		$296K Sell
2,301
-7
-0.3% -$838 0.03% 221
2016
Q2 		$252K Hold
2,308
– – 0.03% 244
2016
Q1 		$219K Buy
2,308
+2
+0.1% +$169 0.03% 258
2015
Q4 		$208K Buy
2,306
+10
+0.4% +$849 0.02% 253
2015
Q3 		$213K Buy
+2,296
New +$202K 0.03% 245

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's ABMD Position: Q4 2022 in Review

Wilbanks Smith & Thomas Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,036 shares — an estimated $500K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in ABMD in Q3 2015 and held it in 29 quarters. The position peaked at $934K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 2,036 Abiomed Inc shares in Q4 2022, an estimated $500K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Abiomed Inc in Q3 2015 and held it in 29 quarters.
  • Wilbanks Smith & Thomas Asset Management's Abiomed Inc position peaked at $934K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.